Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 47

1.

A Complex Role for Calcium Signaling in Colorectal Cancer Development and Progression.

Wang W, Yu S, Huang S, Deng R, Ding Y, Wu Y, Li X, Wang A, Wang S, Chen W, Lu Y.

Mol Cancer Res. 2019 Jul 31. doi: 10.1158/1541-7786.MCR-19-0429. [Epub ahead of print] Review.

PMID:
31366605
2.

Beta-elemene inhibits breast cancer metastasis through blocking pyruvate kinase M2 dimerization and nuclear translocation.

Pan Y, Wang W, Huang S, Ni W, Wei Z, Cao Y, Yu S, Jia Q, Wu Y, Chai C, Zheng Q, Zhang L, Wang A, Sun Z, Huang S, Wang S, Chen W, Lu Y.

J Cell Mol Med. 2019 Jul 25. doi: 10.1111/jcmm.14568. [Epub ahead of print]

3.

Transient receptor potential ion-channel subfamily V member 4: a potential target for cancer treatment.

Yu S, Huang S, Ding Y, Wang W, Wang A, Lu Y.

Cell Death Dis. 2019 Jun 24;10(7):497. doi: 10.1038/s41419-019-1708-9.

4.

Breaking Glucose Transporter 1/Pyruvate Kinase M2 Glycolytic Loop Is Required for Cantharidin Inhibition of Metastasis in Highly Metastatic Breast Cancer.

Pan Y, Zheng Q, Ni W, Wei Z, Yu S, Jia Q, Wang M, Wang A, Chen W, Lu Y.

Front Pharmacol. 2019 May 24;10:590. doi: 10.3389/fphar.2019.00590. eCollection 2019.

5.

Protective Effects of Magnesium Glycyrrhizinate on Methotrexate-Induced Hepatotoxicity and Intestinal Toxicity May Be by Reducing COX-2.

Cao Y, Shi H, Sun Z, Wu J, Xia Y, Wang Y, Wu Y, Li X, Chen W, Wang A, Lu Y.

Front Pharmacol. 2019 Mar 25;10:119. doi: 10.3389/fphar.2019.00119. eCollection 2019.

6.

Correction to: Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells.

Chen W, Pan Y, Wang S, Liu Y, Chen G, Zhou L, Zhang C, Ni W, Wang A, Lu Y, Huang S.

BMC Cancer. 2019 Mar 21;19(1):257. doi: 10.1186/s12885-019-5458-y.

7.

Zhile Capsule Exerts Antidepressant-Like Effects through Upregulation of the BDNF Signaling Pathway and Neuroprotection.

Wu J, Zhang T, Yu L, Huang S, Yang Y, Yu S, Li J, Cao Y, Wei Z, Li X, Wu Y, Chen W, Wang A, Lu Y.

Int J Mol Sci. 2019 Jan 8;20(1). pii: E195. doi: 10.3390/ijms20010195.

8.

Targeting Thioredoxin System with an Organosulfur Compound, Diallyl Trisulfide (DATS), Attenuates Progression and Metastasis of Triple-Negative Breast Cancer (TNBC).

Liu Y, Zhao Y, Wei Z, Tao L, Sheng X, Wang S, Chen J, Ruan J, Liu Z, Cao Y, Shan Y, Wang A, Chen W, Lu Y.

Cell Physiol Biochem. 2018;50(5):1945-1963. doi: 10.1159/000494874. Epub 2018 Nov 5.

9.

A spontaneous metastatic mathematical model in mice for screening anti-metastatic agents.

Li Y, Yue Z, Yu H, Liu X, Tao L, Zhu Z, Fan F, Shen C, Wang A, Chen W, Lu Y.

J Pharmacol Toxicol Methods. 2018 Jul - Aug;92:57-66. doi: 10.1016/j.vascn.2018.03.001. Epub 2018 Mar 14.

PMID:
29550466
10.

Diallyl trisulfides, a natural histone deacetylase inhibitor, attenuate HIF-1α synthesis, and decreases breast cancer metastasis.

Wei Z, Shan Y, Tao L, Liu Y, Zhu Z, Liu Z, Wu Y, Chen W, Wang A, Lu Y.

Mol Carcinog. 2017 Oct;56(10):2317-2331. doi: 10.1002/mc.22686. Epub 2017 Jul 6.

PMID:
28574600
11.

Cryptotanshinone inhibition of mammalian target of rapamycin pathway is dependent on oestrogen receptor alpha in breast cancer.

Pan Y, Shi J, Ni W, Liu Y, Wang S, Wang X, Wei Z, Wang A, Chen W, Lu Y.

J Cell Mol Med. 2017 Sep;21(9):2129-2139. doi: 10.1111/jcmm.13135. Epub 2017 Mar 8.

12.

Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells.

Chen W, Pan Y, Wang S, Liu Y, Chen G, Zhou L, Ni W, Wang A, Lu Y.

BMC Cancer. 2017 Jan 7;17(1):34. doi: 10.1186/s12885-016-3038-y. Erratum in: BMC Cancer. 2019 Mar 21;19(1):257.

13.

Nuclear PKM2 expression, an independent risk factor for ER after curative resection of hepatocellular carcinoma.

Fan F, Wu H, Liu Z, Hou X, Chen W, Wang A, Lu Y.

Biomed Pharmacother. 2016 Dec;84:1858-1864. doi: 10.1016/j.biopha.2016.10.108. Epub 2016 Nov 25.

PMID:
27894667
14.

Prophylaxis of Diallyl Disulfide on Skin Carcinogenic Model via p21-dependent Nrf2 stabilization.

Shan Y, Wei Z, Tao L, Wang S, Zhang F, Shen C, Wu H, Liu Z, Zhu P, Wang A, Chen W, Lu Y.

Sci Rep. 2016 Oct 19;6:35676. doi: 10.1038/srep35676.

15.

Xanthatin anti-tumor cytotoxicity is mediated via glycogen synthase kinase-3β and β-catenin.

Tao L, Sheng X, Zhang L, Li W, Wei Z, Zhu P, Zhang F, Wang A, Woodgett JR, Lu Y.

Biochem Pharmacol. 2016 Sep 1;115:18-27. doi: 10.1016/j.bcp.2016.06.009. Epub 2016 Jun 16.

PMID:
27321043
16.

TRPM8: a potential target for cancer treatment.

Liu Z, Wu H, Wei Z, Wang X, Shen P, Wang S, Wang A, Chen W, Lu Y.

J Cancer Res Clin Oncol. 2016 Sep;142(9):1871-81. doi: 10.1007/s00432-015-2112-1. Epub 2016 Jan 23. Review.

PMID:
26803314
17.
18.

Downregulation of Integrins in Cancer Cells and Anti-Platelet Properties Are Involved in Holothurian Glycosaminoglycan-Mediated Disruption of the Interaction of Cancer Cells and Platelets in Hematogenous Metastasis.

Qian W, Tao L, Wang Y, Zhang F, Li M, Huang S, Wang A, Chen W, Yue Z, Chen L, Liu Y, Huang C, Zhang L, Li Y, Lu Y.

J Vasc Res. 2015;52(3):197-209. doi: 10.1159/000439220. Epub 2015 Oct 22.

PMID:
26488158
19.

Expression of claudin-5, -7, -8 and -9 in cervical carcinoma tissues and adjacent non-neoplastic tissues.

Zhu J, Wang R, Cao H, Zhang H, Xu S, Wang A, Liu B, Wang Y, Wang R.

Int J Clin Exp Pathol. 2015 Aug 1;8(8):9479-86. eCollection 2015.

20.

Paeonol inhibits B16F10 melanoma metastasis in vitro and in vivo via disrupting proinflammatory cytokines-mediated NF-κB and STAT3 pathways.

Zhang L, Tao L, Shi T, Zhang F, Sheng X, Cao Y, Zheng S, Wang A, Qian W, Jiang L, Lu Y.

IUBMB Life. 2015 Oct;67(10):778-88. doi: 10.1002/iub.1435. Epub 2015 Oct 10.

Supplemental Content

Loading ...
Support Center